Careers with Dexcom in Athenry, Galway
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), develops and markets Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes. Since the company’s inception, Dexcom has focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class – while empowering the community to take control of diabetes. Dexcom reported full-year 2022 revenues of $2.9B, a growth of 18% over 2021. Headquartered in San Diego, California, with additional offices in the Americas, Europe, and Asia Pacific, the company employs over 8,000 people worldwide.
Thank you for your interest in careers with Dexcom, a global medical device company and pioneer in Continuous Glucose Monitoring (CGM). We are building our newest manufacturing site in Athenry, Galway and will be scaling the organization rapidly over the next several years.
From the May 5, 2023 IDA Ireland press release:
Subject to planning permission, the Ireland site will be Dexcom’s first manufacturing site in Europe, expanding upon the company’s existing capabilities in the U.S. and Malaysia. The new facility will have the capacity to produce millions of Dexcom CGM sensors each year, helping to improve the lives of people with diabetes around the world. Subject to planning approval, the new facility will be located on the IDA Ireland site at Newford, Athenry.
The facility in Athenry will contain a highly automated and efficient manufacturing operation with an emphasis on green technologies. Dexcom expects to provide about 500 construction jobs while the facility is being built and up to 1,000 high tech graduate and technician level positions once the site is running at full capacity.
“With the continued success of our Dexcom G7 and Dexcom ONE CGM systems in Europe, we are pursuing an ambitious growth strategy that requires increased manufacturing capacity to support our rapidly expanding European user base,” said Barry Regan, Executive Vice President of global operations at Dexcom. “Ireland has an exceptional talent pool and an established MedTech sector, making Athenry the perfect location for us to establish a new, state-of-the-art manufacturing facility.”
Now that the announcement has been made, we are preparing to post our first round of site leadership positions over the next few months. And if you are interested in future roles across Manufacturing (Associate to Lead), Quality (all levels), Strategic Sourcing (all levels), Facilities (all levels), leadership and other roles, please feel free to apply to this general interest posting and we will review your application as those roles open up.
You can also join our Talent Network and get alerts when new roles are posted that match your background. Click here to do so: Dexcom Ireland Careers .
More to come soon, and in the meanwhile please check out this article about the announcement: https://www.idaireland.com/latest-news/press-release/dexcom-selects-ireland-for-first-european-manufacturing-site?s=09
Dexcom Talent Acquisition
To all Staffing and Recruiting Agencies: Our Careers Site is only for individuals seeking a job at Dexcom. Only authorized staffing and recruiting agencies may use this site or to submit profiles, applications or resumes on specific requisitions. Dexcom does not accept unsolicited resumes or applications from agencies. Please do not forward resumes to the Talent Acquisition team, Dexcom employees or any other company location. Dexcom is not responsible for any fees related to unsolicited resumes/applications.